nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
|
Li, Yan-Ruide |
|
|
31 |
C |
p. |
artikel |
2 |
A library of cancer testis specific T cell receptors for T cell receptor gene therapy
|
de Rooij, Marije A.J. |
|
|
31 |
C |
p. |
artikel |
3 |
Allogeneic tumor cell-derived extracellular vesicles stimulate CD8 T cell response in colorectal cancer
|
Gates, Travis J. |
|
|
31 |
C |
p. |
artikel |
4 |
An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response
|
Zeng, Lili |
|
|
31 |
C |
p. |
artikel |
5 |
A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling
|
Petersen, Sven H. |
|
|
31 |
C |
p. |
artikel |
6 |
Bacterial cancer therapy using the attenuated fowl-adapted Salmonella enterica serovar Gallinarum
|
Lim, Daejin |
|
|
31 |
C |
p. |
artikel |
7 |
Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
|
Ni, Jiaojiao |
|
|
31 |
C |
p. |
artikel |
8 |
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
|
Boucher, Justin C. |
|
|
31 |
C |
p. |
artikel |
9 |
Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment
|
Khushalani, Nikhil I. |
|
|
31 |
C |
p. |
artikel |
10 |
CM082 Enhances the Efficacy of Chemotherapeutic Drugs by Inhibiting the Drug Efflux Function of ABCG2
|
Xu, Lejia |
|
|
31 |
C |
p. |
artikel |
11 |
Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy
|
Yang, Yun |
|
|
31 |
C |
p. |
artikel |
12 |
Gaining insights into virotherapy with canine models
|
Léger, Jacob L. |
|
|
31 |
C |
p. |
artikel |
13 |
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment
|
Cristi, Francisca |
|
|
31 |
C |
p. |
artikel |
14 |
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer
|
Minott, Jessica A. |
|
|
31 |
C |
p. |
artikel |
15 |
Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers
|
Chinsuwan, Thanyavi |
|
|
31 |
C |
p. |
artikel |
16 |
Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers
|
Chinsuwan, Thanyavi |
|
|
31 |
C |
p. |
artikel |
17 |
miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration
|
Chen, Rui |
|
|
31 |
C |
p. |
artikel |
18 |
miR-146a: Overcoming coldness in ovarian cancer
|
Ye, Yanqi |
|
|
31 |
C |
p. |
artikel |
19 |
Molecular Therapy Oncology: What’s in a name?
|
Cripe, Timothy P. |
|
|
31 |
C |
p. |
artikel |
20 |
Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma
|
Makielski, Kelly M. |
|
|
31 |
C |
p. |
artikel |
21 |
New advances in cancer therapy targeting TGF-β signaling pathways
|
Shou, Minyue |
|
|
31 |
C |
p. |
artikel |
22 |
Oncolytic virotherapy targeting the IL15 pathway
|
Yoo, So Young |
|
|
31 |
C |
p. |
artikel |
23 |
Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases
|
Yang, Annie |
|
|
31 |
C |
p. |
artikel |
24 |
Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate
|
Sun, Zehua |
|
|
31 |
C |
p. |
artikel |
25 |
Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products
|
O’Brien Gore, Charlotte |
|
|
31 |
C |
p. |
artikel |
26 |
Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer
|
Meissner, Ramona |
|
|
31 |
C |
p. |
artikel |
27 |
Retraction Notice to: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2
|
He, Yuanmin |
|
|
31 |
C |
p. |
artikel |
28 |
Targeting mesothelin in cancer
|
Elbi, Cem |
|
|
31 |
C |
p. |
artikel |
29 |
Targeting the lactic acid metabolic pathway for antitumor therapy
|
Li, Zhi |
|
|
31 |
C |
p. |
artikel |
30 |
Thank you to our 2023 reviewers
|
|
|
|
31 |
C |
p. |
artikel |
31 |
The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges
|
Wei, Ya-Nan |
|
|
31 |
C |
p. |
artikel |
32 |
Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma
|
Hasanpourghadi, Mohadeseh |
|
|
31 |
C |
p. |
artikel |